|
|||||
|
|
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial |
|
| Authors: | Tangelder Marco J D Frison Lars Weaver Douglas Wilcox Robbert G Bylock Anders Emanuelsson Håkan Held Peter Oldgren Jonas |
| Affiliation: | a AstraZeneca R&D, Medical Science, Mölndal, Sweden b Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI c Department of Cardiovascular Medicine, University Hospital, Nottingham, UK d Department of Cardiology, University Hospital, Uppsala, Sweden |
| Abstract: | |
| Keywords: | AF, atrial fibrillation CI, confidence intervals MI, myocardial infarction PCI, percutaneous coronary intervention RIKS-HIA, Register of Information and Knowledge about Swedish Heart intensive care Admissions VKA, vitamin K antagonists |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |